• Study Resource
  • Explore
    • Arts & Humanities
    • Business
    • Engineering & Technology
    • Foreign Language
    • History
    • Math
    • Science
    • Social Science

    Top subcategories

    • Advanced Math
    • Algebra
    • Basic Math
    • Calculus
    • Geometry
    • Linear Algebra
    • Pre-Algebra
    • Pre-Calculus
    • Statistics And Probability
    • Trigonometry
    • other →

    Top subcategories

    • Astronomy
    • Astrophysics
    • Biology
    • Chemistry
    • Earth Science
    • Environmental Science
    • Health Science
    • Physics
    • other →

    Top subcategories

    • Anthropology
    • Law
    • Political Science
    • Psychology
    • Sociology
    • other →

    Top subcategories

    • Accounting
    • Economics
    • Finance
    • Management
    • other →

    Top subcategories

    • Aerospace Engineering
    • Bioengineering
    • Chemical Engineering
    • Civil Engineering
    • Computer Science
    • Electrical Engineering
    • Industrial Engineering
    • Mechanical Engineering
    • Web Design
    • other →

    Top subcategories

    • Architecture
    • Communications
    • English
    • Gender Studies
    • Music
    • Performing Arts
    • Philosophy
    • Religious Studies
    • Writing
    • other →

    Top subcategories

    • Ancient History
    • European History
    • US History
    • World History
    • other →

    Top subcategories

    • Croatian
    • Czech
    • Finnish
    • Greek
    • Hindi
    • Japanese
    • Korean
    • Persian
    • Swedish
    • Turkish
    • other →
 
Profile Documents Logout
Upload
BRCA1/2 Ashkenazi Founder Mutation Panel
BRCA1/2 Ashkenazi Founder Mutation Panel

... approximately 1/40. The National Comprehensive Cancer Network (NCCN) 1 recommends that individuals of Ashkenazi Jewish descent should first be tested for the three known founder mutations. Given the high frequency of these mutations in this population, testing for all three founder mutations is reco ...
Ready For Primetime Monisha Pujari, MD
Ready For Primetime Monisha Pujari, MD

... actual genetic test, for best results, should be based on a reliable and FDA-approved platform. Second, the results of the test should be coupled to an accurate dosing algorithm, for clinical applicability. Third, minimizing product delivery time is important. Providing the results within twenty fou ...
Morphine (oral)
Morphine (oral)

... increases this risk as practitioners do not usually have access to the patient notes and will have to rely on the information that they are given by the patient or their carer(s). ❙❙ Opioid drugs include: buphrenorphine, codeine, diamorphine, dipipanone, fentanyl, hydromorphone, meptazinol, methadon ...
Antibiotic Safety Assessment
Antibiotic Safety Assessment

... figures for drugs other than antimicrobials were 17 and 16%, showing that toxicity observed during the development phase is viewed as less of a problem with antibiotics than with other drugs [1,2]. In the United States, adverse drug reactions (ADR) cause about 100 000 deaths each year, making them t ...
Thalassaemia: The Biography
Thalassaemia: The Biography

... Chapter 5, The molecular era and the birth of molecular medicine, is to me the best part of this book. Here, Sir David documents a lockstep between sequential advances in molecular genetics and our understanding of the molecular basis of the mutations causing thalassemia. For example, incorporation ...
Procedural Sedation Course
Procedural Sedation Course

... • muscle rigidity, random movements, nystagmus ...
November 2013 PBAC Meeting Outcomes
November 2013 PBAC Meeting Outcomes

Anti Retro Viral Therapy
Anti Retro Viral Therapy

... Name Of the Drugs Zidovudine Stavudine Drugs Supplied Lamivudine By NACO at ...
ISSUE BRIEF - Friends of Cancer Research
ISSUE BRIEF - Friends of Cancer Research

... With the advent of more effective drugs to treat some forms of cancer has come a desire for greater efficiency in drug development. Particularly in situations where clear benefit is being observed for conditions that otherwise lack satisfactory treatment options, the traditional stepwise approach to ...
All Users of Rats and Mice - University of Minnesota health sciences
All Users of Rats and Mice - University of Minnesota health sciences

... increased blood levels of those drugs. At higher doses, some renal effects may be seen as well. No studies of effects in pregnancy have been completed (pregnant humans only use it on advice from their doctors) and it is excreted in small amounts into milk. Carprofen Carprofen (Rimadyl) is an NSAID w ...
David Cousins
David Cousins

... protocol of drawing up and labelling thiopentone prior to a shift was changed to not drawing up thiopentone. • A category 1 section was called. After transferring the patient onto the operating table the AAGBI monitoring was attached and the level of block was confirmed as a T2 sensory block . As re ...
urine drug tests in a private chronic pain practice
urine drug tests in a private chronic pain practice

... permission to do this as part of the opioid agreement they signed when first seen, many had not been tested in a long time and were not expecting it. Some long-term patients had not had an initial urine drug test (UDT). The patients were not observed urinating, but the medical assistant checked the ...
Mendelian Genetics 3
Mendelian Genetics 3

... A. Men only get one X chromosome. If there happens to be a recessive gene on the X, men don’t have a dominant gene that can cancel it out. They are going to express it. B. Females have a far greater chance of having a dominant gene to hide the recessive one. C. Sex-linked traits – traits carried by ...
Take Meds Faithfully - Consumer Reports Health
Take Meds Faithfully - Consumer Reports Health

New Neonatal Abstinence Syndrome in NICU
New Neonatal Abstinence Syndrome in NICU

... drugs and are enrolled in treatment programs in order to stop taking or continue not taking the drugs. Methadone is in a class of medications called opiate (narcotic) analgesics. Methadone works to treat pain by changing the way the brain and nervous system respond to pain. It also works as a substi ...
Food Interactions with Prescription Drugs
Food Interactions with Prescription Drugs

... K level can interfere with blood clotting. Anticoagulants prevent blood clot formation that can cause a heart attack or stroke. One example is warfarin (Coumadin), a blood thinner. Vitamin K is an antagonist — it makes the blood clot— and it inhibits the action of warfarin, which is highly sensitive ...
Drugs go wireless
Drugs go wireless

... Some device makers have been able to demonstrate clinically that their technologies do that. They’ve also been able to convince drug developers that the devices may offer a way to extend a drug’s market exclusivity and thwart generic competition. But the success of digital drugs hinges largely upon ...
Facing up to Complex Inheritance Patterns
Facing up to Complex Inheritance Patterns

... promoter region of the serotonin transporter (5-HT T) gene was found to moderate the influence of stressful life events on depression. Individuals with one or two copies of the short allele of the 5-HT T promoter polymorphism exhibited more depressive symptoms, diagnosable depression, and suicidalit ...
Guidance on reporting an adverse incident
Guidance on reporting an adverse incident

... ensure that the incident is reported appropriately. ...
Do you know the genetic Lingo:
Do you know the genetic Lingo:

... from three individuals: a mother, her child, and the child's alleged father. Each autoradiograph compares equivalent DNA segments from the three individuals. The two dark bands in each column represent one individual's DNA segments -- one inherited from that individual's biological mother and the ot ...
Statement of Rationale
Statement of Rationale

... clinics. Use of advanced clinical skills while assisting the physician and performing direct patient care. Prerequisite: Health 51A (may be taken concurrently), Medical Assisting 70A and Medical Assisting 75. Completed with a grade of C or higher. 2 hours lecture, 3 hours laboratory. [Typical contac ...
MOLECULAR BASIS OF DRUG-RESISTANT TUBERCULOSIS
MOLECULAR BASIS OF DRUG-RESISTANT TUBERCULOSIS

... mutations in three TB genes: rpoB (associated with rifampin resistance), and katG and inhA (mutations associated with isoniazid resistance) the molecular probe was ≥99 percent sensitive and specific for multidrug TB resistance, compared with standard drug-susceptibility testing; results were ...
Lecture
Lecture

... Now what? ...
Name - KAMS7THGRADETEAM
Name - KAMS7THGRADETEAM

... Sickle-cell disease is a genetic disorder that affects the hemoglobin, the protein in the blood that carries oxygen. People with sickle-cell disease suffer from lack of oxygen in the blood and experience pain and weakness. The allele that causes sickle-cell is codominant with the normal allele. Peop ...
Health - Windsor C-1 School District
Health - Windsor C-1 School District

... light up more often. ...
< 1 ... 1063 1064 1065 1066 1067 1068 1069 1070 1071 ... 1254 >

Pharmacogenomics

Pharmacogenomics (a portmanteau of pharmacology and genomics) is the study of the role of genetics in drug response. It deals with the influence of acquired and inherited genetic variation on drug response in patients by correlating gene expression or single-nucleotide polymorphisms with drug absorption, distribution, metabolism and elimination, as well as drug receptor target effects. The term pharmacogenomics is often used interchangeably with pharmacogenetics. Although both terms relate to drug response based on genetic influences, pharmacogenetics focuses on single drug-gene interactions, while pharmacogenomics encompasses a more genome-wide association approach, incorporating genomics and epigenetics while dealing with the effects of multiple genes on drug response.Pharmacogenomics aims to develop rational means to optimize drug therapy, with respect to the patients' genotype, to ensure maximum efficacy with minimal adverse effects. Through the utilization of pharmacogenomics, it is hoped that drug treatments can deviate from what is dubbed as the “one-dose-fits-all” approach. It attempts to eliminate the trial-and-error method of prescribing, allowing physicians to take into consideration their patient’s genes, the functionality of these genes, and how this may affect the efficacy of the patient’s current and/or future treatments (and where applicable, provide an explanation for the failure of past treatments). Such approaches promise the advent of ""personalized medicine""; in which drugs and drug combinations are optimized for each individual's unique genetic makeup. Whether used to explain a patient’s response or lack thereof to a treatment, or act as a predictive tool, it hopes to achieve better treatment outcomes, greater efficacy, minimization of the occurrence of drug toxicities and adverse drug reactions (ADRs). For patients who have lack of therapeutic response to a treatment, alternative therapies can be prescribed that would best suit their requirements. In order to provide pharmacogenomic-based recommendations for a given drug, two possible types of input can be used: genotyping or exome or whole genome sequencing. Sequencing provides many more data points, including detection of mutations that prematurely terminate the synthesized protein (early stop codon).
  • studyres.com © 2025
  • DMCA
  • Privacy
  • Terms
  • Report